Growth Metrics

Moderna (MRNA) Other Working Capital Changes (2018 - 2025)

Historic Other Working Capital Changes for Moderna (MRNA) over the last 8 years, with Q3 2025 value amounting to -$42.0 million.

  • Moderna's Other Working Capital Changes rose 8699.69% to -$42.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$154.0 million, marking a year-over-year increase of 8552.63%. This contributed to the annual value of -$439.0 million for FY2024, which is 7868.93% up from last year.
  • According to the latest figures from Q3 2025, Moderna's Other Working Capital Changes is -$42.0 million, which was up 8699.69% from $196.0 million recorded in Q2 2025.
  • In the past 5 years, Moderna's Other Working Capital Changes ranged from a high of $3.7 billion in Q1 2021 and a low of -$1.6 billion during Q4 2021
  • For the 5-year period, Moderna's Other Working Capital Changes averaged around -$196.0 million, with its median value being -$233.0 million (2021).
  • Examining YoY changes over the last 5 years, Moderna's Other Working Capital Changes showed a top increase of 9155000.0% in 2021 and a maximum decrease of 59574.47% in 2021.
  • Moderna's Other Working Capital Changes (Quarter) stood at -$1.6 billion in 2021, then rose by 8.77% to -$1.5 billion in 2022, then soared by 39.5% to -$887.0 million in 2023, then soared by 70.46% to -$262.0 million in 2024, then soared by 83.97% to -$42.0 million in 2025.
  • Its Other Working Capital Changes stands at -$42.0 million for Q3 2025, versus $196.0 million for Q2 2025 and -$46.0 million for Q1 2025.